ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 150 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,160 | -86.1% | 327,468 | -46.1% | 0.00% | – |
| Q2 2023 | $309,696 | -25.9% | 607,246 | -8.5% | 0.00% | – |
| Q1 2023 | $418,007 | -54.6% | 663,501 | -53.3% | 0.00% | – |
| Q4 2022 | $921,614 | -28.2% | 1,419,833 | +90.3% | 0.00% | – |
| Q3 2022 | $1,283,000 | +17.9% | 746,011 | -14.9% | 0.00% | – |
| Q2 2022 | $1,088,000 | +73.2% | 877,041 | -8.9% | 0.00% | – |
| Q1 2022 | $628,000 | -36.0% | 962,544 | +7.0% | 0.00% | – |
| Q4 2021 | $981,000 | -43.0% | 899,291 | -4.9% | 0.00% | – |
| Q3 2021 | $1,720,000 | -37.7% | 945,419 | -9.6% | 0.00% | – |
| Q2 2021 | $2,763,000 | -17.0% | 1,046,336 | +13.2% | 0.00% | – |
| Q1 2021 | $3,327,000 | +6.0% | 924,200 | -25.8% | 0.00% | – |
| Q4 2020 | $3,140,000 | +40.6% | 1,245,908 | +40.6% | 0.00% | – |
| Q3 2020 | $2,233,000 | -26.3% | 886,065 | -4.1% | 0.00% | -100.0% |
| Q2 2020 | $3,030,000 | -7.7% | 923,916 | -31.0% | 0.00% | 0.0% |
| Q1 2020 | $3,282,000 | -41.1% | 1,339,584 | +13.5% | 0.00% | 0.0% |
| Q4 2019 | $5,573,000 | -21.5% | 1,180,702 | -28.8% | 0.00% | -50.0% |
| Q3 2019 | $7,097,000 | -12.1% | 1,658,072 | +19.7% | 0.00% | 0.0% |
| Q2 2019 | $8,075,000 | +71.4% | 1,385,120 | +13.2% | 0.00% | +100.0% |
| Q1 2019 | $4,710,000 | +76.5% | 1,223,287 | -14.2% | 0.00% | 0.0% |
| Q4 2018 | $2,668,000 | -29.1% | 1,426,340 | +21.3% | 0.00% | 0.0% |
| Q3 2018 | $3,762,000 | -1.7% | 1,175,472 | -7.3% | 0.00% | 0.0% |
| Q2 2018 | $3,828,000 | -28.3% | 1,267,573 | -6.9% | 0.00% | 0.0% |
| Q1 2018 | $5,339,000 | -14.2% | 1,362,053 | -9.4% | 0.00% | -50.0% |
| Q4 2017 | $6,223,000 | -24.8% | 1,503,305 | +11.6% | 0.00% | 0.0% |
| Q3 2017 | $8,274,000 | -6.8% | 1,347,589 | -5.6% | 0.00% | -33.3% |
| Q2 2017 | $8,881,000 | -64.8% | 1,427,600 | -64.1% | 0.00% | -25.0% |
| Q1 2017 | $25,220,000 | +41.6% | 3,978,350 | +19.5% | 0.00% | +33.3% |
| Q4 2016 | $17,808,000 | +127.2% | 3,328,802 | +139.1% | 0.00% | 0.0% |
| Q3 2016 | $7,839,000 | +1.8% | 1,392,361 | -0.8% | 0.00% | 0.0% |
| Q2 2016 | $7,702,000 | -25.6% | 1,402,974 | +0.5% | 0.00% | -25.0% |
| Q1 2016 | $10,359,000 | -23.0% | 1,396,100 | -13.7% | 0.00% | -20.0% |
| Q4 2015 | $13,447,000 | -3.1% | 1,618,205 | +5.1% | 0.01% | 0.0% |
| Q3 2015 | $13,872,000 | -23.7% | 1,539,622 | +1.7% | 0.01% | -16.7% |
| Q2 2015 | $18,169,000 | +23.5% | 1,514,071 | +10.9% | 0.01% | +20.0% |
| Q1 2015 | $14,707,000 | +119.1% | 1,365,615 | +3.2% | 0.01% | +150.0% |
| Q4 2014 | $6,711,000 | +99.8% | 1,323,484 | +4.0% | 0.00% | +100.0% |
| Q3 2014 | $3,359,000 | -29.9% | 1,272,737 | +7.1% | 0.00% | -50.0% |
| Q2 2014 | $4,790,000 | -9.8% | 1,188,377 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $5,310,000 | +17.8% | 1,159,493 | +11.6% | 0.00% | 0.0% |
| Q4 2013 | $4,509,000 | +68.1% | 1,038,934 | +52.6% | 0.00% | +100.0% |
| Q3 2013 | $2,682,000 | +133.8% | 680,888 | +25.3% | 0.00% | 0.0% |
| Q2 2013 | $1,147,000 | – | 543,315 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 12,546,493 | $22,835,000 | 1.71% |
| MSD Partners, L.P. | 15,151,516 | $27,576,000 | 0.84% |
| MSD Partners, L.P. | 7,575,758 | $13,788,000 | 0.42% |
| CHIRON CAPITAL MANAGEMENT, LLC | 198,002 | $360,000 | 0.26% |
| Avidity Partners Management LP | 3,000,000 | $5,460,000 | 0.12% |
| Old West Investment Management, LLC | 211,513 | $384,000 | 0.10% |
| MAGNOLIA CAPITAL ADVISORS LLC | 103,239 | $188,000 | 0.07% |
| Virtus ETF Advisers LLC | 72,060 | $131,000 | 0.06% |
| ACT WEALTH MANAGEMENT, LLC | 34,454 | $91,000 | 0.06% |
| Allred Capital Management, LLC | 53,000 | $96,000 | 0.05% |